These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Doppler flowmeter evaluation of the effects of the administration of buflomedil (irrodan) on peripheral circulation in patients with obstructive chronic arteriopathy]. Abate S, Ferulano GP, Vanni L, Dilillo S, Picilli M, D'Alessio E. Minerva Cardioangiol; 1985 Nov; 33(11):749-56. PubMed ID: 2935748 [No Abstract] [Full Text] [Related]
23. [Clinical experience and instrumental evaluation of buflomedil hydrochloride in the therapy of chronic obliterative arteriopathies of the legs]. Lucisano V, Margheriti R, Matone P, Morrieri C, Rugolo A, Corsi V. Clin Ter; 1986 Jun 30; 117(6):499-509. PubMed ID: 3527536 [No Abstract] [Full Text] [Related]
25. [Effect of buflomedil perfusion on peripheral tissue oxygenation during transluminal angioplasty in patients with advanced arteriopathy of the lower limbs]. Joffre F, Meites G, Rousseau H, Staffin C, Allaert FA, Pelat P. Ann Radiol (Paris); 1994 Jun 30; 37(3):239-44. PubMed ID: 8092756 [Abstract] [Full Text] [Related]
26. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities]. Maksimović ZV. Srp Arh Celok Lek; 1999 Jun 30; 127(7-8):249-53. PubMed ID: 10624398 [Abstract] [Full Text] [Related]
27. Evaluation of the therapeutic efficacy and tolerability of levocarnitine propionyl in the treatment of chronic obstructive arteriopathies of the lower extremities: a multicentre controlled study vs. placebo. Coto V, D'Alessandro L, Grattarola G, Imparato L, Lingetti M, Mancini M, Nolfe G, Rengo F. Drugs Exp Clin Res; 1992 Jun 30; 18(1):29-36. PubMed ID: 1600865 [Abstract] [Full Text] [Related]
28. [Treatment of chronic obliterative arteriopathy of the legs in the second Fontaine's stage. Personal experience with a buflomedil-pentoxifylline-defibrotide combination]. Marci M, Albiani B, Ricci M, Russo F. Clin Ter; 1995 Mar 30; 146(3):211-4. PubMed ID: 7789083 [Abstract] [Full Text] [Related]
32. [Effects of metoprolol on the peripheral circulation in patients with peripheral vascular disease]. Diehm C, Mörl H, Schettler G. Z Kardiol; 1983 Jan 30; 72(1):44-7. PubMed ID: 6837085 [Abstract] [Full Text] [Related]
33. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program . Natl Toxicol Program Tech Rep Ser; 1993 Sep 30; 422():1-340. PubMed ID: 12616289 [Abstract] [Full Text] [Related]
35. Thrombin and platelet inhibition with low-dose calcium-heparin in comparison with ASA in patients with peripheral arterial occlusive disease at Leriche-Fontaine IIb class. Allegra C, Pollari G, Carioti B, Sardina M. Int J Clin Pharmacol Ther; 1994 Dec 30; 32(12):646-51. PubMed ID: 7881702 [Abstract] [Full Text] [Related]
37. A new study demonstrates the efficacy of naftidrofuryl in the treatment of intermittent claudication. Findings of the Naftidrofuryl Clinical Ischemia Study (NCIS). Kieffer E, Bahnini A, Mouren X, Gamand S. Int Angiol; 2001 Mar 30; 20(1):58-65. PubMed ID: 11342997 [Abstract] [Full Text] [Related]
38. [Comparative study of various schedules of buflomedil treatment in peripheral arterial insufficiency of the lower limbs. Evaluation of its therapeutic efficacy]. Paoletti V, Mammarella A, Alessandrini A, Barlattani M. Clin Ter; 1984 Jul 15; 110(1):29-36. PubMed ID: 6237843 [No Abstract] [Full Text] [Related]